Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-577P refers to a specific pseudogene related to the U6 small nuclear RNA. U6 small nuclear RNA (U6 snRNA) is a highly conserved, essential component of the spliceosome complex, playing a key role in pre-mRNA splicing by contributing to the catalysis of intron removal in the nucleus of eukaryotic cells[1][3]. However, RNU6-577P is classified as a pseudogene, meaning it is a genomic sequence closely resembling the functional U6 snRNA gene but containing mutations or structural changes that prevent it from producing functional RNA[2][5]. Such U6 snRNA pseudogenes are common within vertebrate genomes and are generally considered to be non-functional, not participating in biological processes such as splicing or being involved in disease mechanisms or drug interactions. They likely exist as evolutionary remnants and contribute to the background genetic sequence, with no known physiological or pathological roles[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 577, pseudogene (RNU6-577P).